Pricing Log in Create free account

Adagene Inc. Sponsored ADR (ADAG) vs NervGen Pharma Corp. (NGEN)

Adagene Inc. Sponsored ADR and NervGen Pharma Corp. are both Biotechnology companies. Adagene Inc. Sponsored ADR and NervGen Pharma Corp. are of similar size ($143.1M and $134.3M). Across the 7 metrics below, Adagene Inc. Sponsored ADR leads on 5 and NervGen Pharma Corp. on 2.

Valuation

Metric ADAG NGEN Biotechnology median
P/E — n/m 10.60
P/S — n/m 9.40
P/B n/m 3.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield — (17.89%) (32.88%)
Free cash flow yield 0.00% (14.96%) (23.13%)

Profitability

Metric ADAG NGEN Biotechnology median
Gross margin — — 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (94.85%) (51.96%)
Return on assets 0.00% (40.66%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAG NGEN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 49.15% (68.14%) 29.88%
Revenue growth, 5-year CAGR 61.38% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADAG NGEN Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.02 2.07 4.97
Net debt to EBITDA 3.46 0.95 1.01

Dividend

Metric ADAG NGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADAG NGEN Biotechnology median
Market cap 134.28m 143.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack